Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastases in malignant melanoma

M G O'Rourke, A Louie

    The Australian and New Zealand Journal of Surgery
    |April 1, 1982
    PubMed
    Summary

    Metastatic melanoma often progresses rapidly, with most patients developing metastases within three years. Survival is poor, with only 14 of 76 patients alive, and limited to those with localized disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    Wooden hutch space allowance influences male Holstein calf health, performance, daily lying time, and respiratory immunity.

    Journal of dairy science·2016
    Same author

    Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.

    Antimicrobial agents and chemotherapy·2012
    Same author

    Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system.

    mBio·2011
    Same author

    Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets.

    Antimicrobial agents and chemotherapy·2011
    Same author

    Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia.

    Antimicrobial agents and chemotherapy·2011

    Area of Science:

    • Oncology
    • Dermatology
    • Pathology

    Background:

    • Metastatic melanoma is a significant health concern.
    • Understanding its progression and survival patterns is crucial for patient outcomes.

    Purpose of the Study:

    • To analyze the clinical presentation, metastatic patterns, and survival rates of 76 patients with metastatic melanoma over a decade.
    • To identify prognostic factors influencing survival in metastatic melanoma.

    Main Methods:

    • Retrospective review of 76 metastatic melanoma cases over ten years.
    • Analysis of time to metastasis, site of first metastasis, and histological features.
    • Evaluation of survival data and patterns of disease spread.

    Main Results:

    • 64.5% developed metastases within 12 months, 80% by three years.
    • Primary metastasis sites: 65% regional lymph nodes, 22% viscera.
    • Only 14 of 76 patients survived, nine without evidence of disease; survival was limited to localized or regional disease.

    Conclusions:

    • Metastatic melanoma exhibits rapid progression and widespread dissemination.
    • Survival is significantly impacted by the extent of metastasis, with localized or regional disease offering the only chance of long-term survival.

    Related Experiment Videos